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Background: To investigate the relationship between periodontal disease indexes (PDI) and endothelial dysfunction by means of asymmetric 
dimethyl-arginine (ADMA) in conditions of both increased and decreased systemic inflammation in the setting of hypertension.
Methods: We studied 108 - aged 52±9 years - untreated hypertensive subjects (24h systolic/diastolic blood pressure [BP] 131±11/83±9mmHg) 
with diverse severity of periodontal disease (i.e. mean clinical loss of attachment [CLA], maximum probe depth [MPD] and gingival index [GI]). 
Subjects underwent office and ambulatory BP measurements, echocardiography, and periodontal examination; while from fasting venous blood 
samples we assessed metabolic profile, and we measured ADMA and high sensitivity C reactive protein (hsCRP) levels. With respect to the median 
of hsCRP and ADMA (1.79 mg/l and 0.81 μmol/l, respectively) the study population was divided in four groups: low-ADMA/low-hsCRP (n=30), low-
ADMA/high-hsCRP (n=27), high-ADMA /low-hsCRP (n=21) and high-ADMA/high-hsCRP (n=30).
Results: High-ADMA/high-hsCRP group resulted significantly older compared with both low-ADMA/low-hsCRP and high-ADMA/high-hsCRP groups, 
while high compared with low-ADMA groups demonstrated increased low-density lipoprotein cholesterol. PDIs were increased in those with high 
compared with those with low-hsCRP, while the addition of high-ADMA contributed significantly to that comparison. Log(10)(hsCRP) and log(10)
(ADMA) were correlated with CLA (β=0.35, p=0.01 and β=0.25, p=0.012, respectively), MPD (β=0.25, p=0.002 and β=0.32, p=0.008, respectively) 
and GI (β=0.34, p<0.001 and β=0.36, p<0.001, respectively). After adjustment for confounders, high-ADMA/high-hsCRP was significantly associated 
- by means of adjusted z-scores - with mean clinical loss of attachment, maximum probe depth and gingival index by 10.33, 8.84 and 2.74 times 
more often with respect to the low-ADMA/low-hsCRP pattern.
Conclusion: PDI are associated in a dose-dependent manner with ADMA in untreated hypertensives and increased systemic inflammation further 
contributes to that phenomenon.
